Glaukos Return on Tangible Equity 2014-2025 | GKOS

Current and historical return on tangible equity values for Glaukos (GKOS) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Glaukos Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.12B $0.44B -32.35%
2024-12-31 $-0.15B $0.44B -49.16%
2024-09-30 $-0.15B $0.33B -68.81%
2024-06-30 $-0.16B $0.32B -96.22%
2024-03-31 $-0.14B $0.10B -121.29%
2023-12-31 $-0.14B $0.11B -107.36%
2023-09-30 $-0.13B $0.12B -94.51%
2023-06-30 $-0.13B $0.13B -85.81%
2023-03-31 $-0.14B $0.14B -87.36%
2022-12-31 $-0.10B $0.16B -56.74%
2022-09-30 $-0.09B $0.17B -49.39%
2022-06-30 $-0.06B $0.18B -29.80%
2022-03-31 $-0.03B $0.21B -14.70%
2021-12-31 $-0.05B $0.19B -26.89%
2021-09-30 $-0.04B $0.20B -19.36%
2021-06-30 $-0.06B $0.17B -29.23%
2021-03-31 $-0.08B $0.17B -37.99%
2020-12-31 $-0.12B $0.24B -53.72%
2020-09-30 $-0.07B $0.23B -33.11%
2020-06-30 $-0.07B $0.23B -33.81%
2020-03-31 $-0.04B $0.20B -18.45%
2019-12-31 $0.02B $0.23B 8.12%
2019-09-30 $-0.02B $0.19B -10.31%
2019-06-30 $-0.01B $0.19B -6.76%
2019-03-31 $-0.01B $0.19B -6.58%
2018-12-31 $-0.01B $0.17B -8.32%
2018-09-30 $-0.01B $0.16B -9.56%
2018-06-30 $-0.01B $0.15B -4.36%
2018-03-31 $0.00B $0.14B -3.05%
2017-12-31 $0.00B $0.14B 0.00%
2017-09-30 $0.00B $0.13B -0.84%
2017-06-30 $0.00B $0.12B -0.88%
2017-03-31 $0.00B $0.12B 3.74%
2016-12-31 $0.00B $0.11B 4.00%
2016-09-30 $0.00B $0.10B 2.14%
2016-06-30 $0.00B $0.10B -1.13%
2016-03-31 $-0.04B $0.09B -41.06%
2015-12-31 $-0.04B $0.09B -62.98%
2015-09-30 $-0.04B $0.08B -120.30%
2015-06-30 $-0.04B $0.08B -318.37%
2015-03-31 $-0.01B $-0.02B 105.88%
2014-12-31 $-0.01B $-0.02B 282.35%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $5.665B $0.383B
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $187.241B 82.01
Thermo Fisher Scientific (TMO) United States $156.717B 18.96
Edwards Lifesciences (EW) United States $44.271B 29.03
Alcon (ALC) Switzerland $43.692B 29.53
IDEXX Laboratories (IDXX) United States $42.156B 48.44
DexCom (DXCM) United States $32.541B 50.30
IQVIA Holdings (IQV) United States $27.478B 15.39
Mettler-Toledo (MTD) United States $24.793B 29.49
STERIS (STE) Ireland $23.682B 26.08
Waters (WAT) United States $20.593B 29.06
SONOVA HOLDING (SONVY) Switzerland $18.749B 0.00
Hologic (HOLX) United States $14.391B 15.64
Sysmex ADR (SSMXY) Japan $10.512B 29.82
Penumbra (PEN) United States $9.810B 76.99
Masimo (MASI) United States $9.055B 33.40
Globus Medical (GMED) United States $8.231B 19.61
Teleflex (TFX) United States $5.412B 8.93
TransMedics (TMDX) United States $4.833B 105.06
Integer Holdings (ITGR) United States $4.188B 21.94
PROCEPT BioRobotics (PRCT) United States $3.437B 0.00
LivaNova (LIVN) United Kingdom $2.546B 15.16
Veracyte (VCYT) United States $2.187B 30.69
Nihon Kohden (NHNKY) Japan $2.115B 24.25
Elekta AB (EKTAY) Sweden $1.972B 17.72
Alphatec Holdings (ATEC) United States $1.715B 0.00
Tandem Diabetes Care (TNDM) United States $1.435B 0.00
Artivion (AORT) United States $1.241B 116.20
Pulse Biosciences (PLSE) United States $1.125B 0.00
OPKO Health (OPK) United States $1.071B 0.00
Integra LifeSciences Holdings (IART) United States $0.997B 5.30
Beta Bionics (BBNX) United States $0.829B 0.00
SiBone (SIBN) United States $0.802B 0.00
IRadimed (IRMD) United States $0.763B 38.72
RxSight (RXST) United States $0.606B 0.00
Mesa Laboratories (MLAB) United States $0.570B 13.36
AVANOS MEDICAL, INC (AVNS) United States $0.570B 8.86
Delcath Systems (DCTH) United States $0.556B 0.00
OrthoPediatrics (KIDS) United States $0.537B 0.00
AxoGen (AXGN) United States $0.463B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.446B 0.00
AngioDynamics (ANGO) United States $0.443B 0.00
Treace Medical Concepts (TMCI) United States $0.388B 0.00
NeuroPace (NPCE) United States $0.388B 0.00
ClearPoint Neuro (CLPT) United States $0.360B 0.00
Semler Scientific (SMLR) United States $0.354B 9.41
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
908 Devices (MASS) United States $0.261B 0.00
Neuronetics (STIM) United States $0.251B 0.00
Tactile Systems Technology (TCMD) United States $0.233B 14.13
Sight Sciences (SGHT) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.216B 0.00
Anteris Technologies Global (AVR) Australia $0.185B 0.00
Biosig Technologies (BSGM) United States $0.183B 0.00
Spectral Diagnostics (EDTXF) Canada $0.177B 0.00
Inogen (INGN) United States $0.173B 0.00
CVRx (CVRX) United States $0.172B 0.00
Rapid Micro Biosystems (RPID) United States $0.165B 0.00
LENSAR (LNSR) United States $0.153B 0.00
Lucid Diagnostics (LUCD) United States $0.138B 0.00
Accuray (ARAY) United States $0.129B 0.00
Atossa Genetics (ATOS) United States $0.113B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Microbot Medical (MBOT) United States $0.091B 0.00
Sensus Healthcare (SRTS) United States $0.084B 51.00
EnVVeno Medical (NVNO) United States $0.079B 0.00
InspireMD (NSPR) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Spectral AI (MDAI) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.048B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
WORK Medical Technology Group (WOK) China $0.013B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.22
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00